GSK seeks for ways to “contribute” in easing “access to medicines” worldwide. Last week, GlaxoSmithKline, the giant among the “London-listed pharmaceuticals”, reported of its “evolving” approach towards “filing and enforcing patents”, whereby reflecting “a country’s wealth” through “IP protection”....